IGHE and Alzheimer disease: Results from the animal experiments demonstrated that DNCB successfully induced a mouse model exhibiting typical AD features, including significant pathological skin changes (epidermal thickening, inflammatory infiltration, hyperkeratosis, and necrotic cell debris) and dose-dependent increases in serum IgE levels.